Mr John Alan Littleford, DO in Parker, CO - Pain Medicine

Mr John Alan Littleford, DO is a Pain Medicine - Pain Medicine physician based in Parker, Colorado. Mr John Alan Littleford is licensed to practice in Colorado (license number 18185) and his current practice location is 10450 S Progress Way, A105, Parker, Colorado. He can be reached at his office (for appointments etc.) via phone at (303) 841-0222.

NPI number for Mr John Alan Littleford is 1053411421 and his current mailing address is 10450 S Progress Way, A105, Parker, Colorado. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1053411421.

Contact Information

	Mr John Alan Littleford, DO
	10450 S Progress Way, A105, Parker, CO 80134-4036
	(303) 841-0222
	(303) 841-3988

Physician's Profile

Full Name	Mr John Alan Littleford
Gender	Male
Speciality	Pain Medicine - Pain Medicine
Location	10450 S Progress Way, Parker, Colorado
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1053411421
Provider Enumeration Date: 09/25/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Mr John Alan Littleford such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053411421	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	18185 (Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr John Alan Littleford is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr John Alan Littleford, DO 10450 S Progress Way, A105, Parker, CO 80134-4036 Ph: (303) 841-0222	Mr John Alan Littleford, DO 10450 S Progress Way, A105, Parker, CO 80134-4036 Ph: (303) 841-0222

News Archive

Oral garlic tablets shows no effect in clearing vaginal thrush, says study

Led by University of Melbourne PhD candidate Cathy Watson also of the Royal Women's Hospital, the findings were published online in the British Journal of Obstetrics and Gynaecology.

Oasmia announces topline results from head-to-head comparison study of Paclical and Abraxane

Oasmia Pharmaceutical AB, developer of a new generation of drugs within human and veterinary oncology, announced today the topline findings from a head-to-head comparison study of its lead human cancer product candidate Paclical and Celgene's Abraxane, which show similar pharmacokinetic (PK) profiles of the two products. The study was conducted in women with metastatic breast cancer.

Patients should wait at least six weeks to resume driving following shoulder replacement surgery

More than 53,000 Americans have total shoulder joint replacement (SJR) surgery each year, and yet the effects of this surgery on a patient's ability to safely drive a vehicle, and the appropriate recovery time before patients should return to driving, have yet to be determined.

Study reveals promising strategy against bladder cancer metastasis

The popular kids' card game "Exploding Kittens" teaches a concept critical to cancer science: When a player plays a "Nope" card, the subsequent player may lay another "Nope", thus creating a double-negative that becomes a positive, allowing the initial action to proceed.

Scientists identify key factor that drives resistance to cancer drug

Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors - such as those of the breast, prostate, lung and colon - that have metastasized, or spread, throughout the body. A team of scientists led by Fred Hutchinson Cancer Research Center has discovered a key factor that drives this drug resistance - information that ultimately may be used to improve the effectiveness of therapy and buy precious time for patients with advanced cancer.

Mr John Alan Littleford, DO - Pain Medicine in Parker, CO